WITHDRAWN: α-SMA/VCAM-1 Dual-Targeted Nanoplatform Improves Drug Release and Therapeutic Efficacy in Liver Fibrosis
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
This article has been withdrawn by bioRxiv because it was submitted with false information